What are the guidelines for discontinuing lithium (lithium carbonate) therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guidelines for Discontinuing Lithium

Lithium discontinuation should be done gradually over several weeks to months rather than abruptly, as abrupt discontinuation is associated with a 7-fold increase in suicide attempts and a 9-fold increase in completed suicides in bipolar patients. 1

Risk Assessment Before Discontinuation

Before considering lithium discontinuation, evaluate:

  • Current clinical stability
  • History of previous episodes and their severity
  • Risk of suicide
  • Patient's preference after thorough education about risks
  • Availability of alternative treatment options

Specific Discontinuation Protocol

When to Consider Discontinuation

  • After at least 2-3 years of stability in bipolar disorder 1
  • When significant adverse effects persist despite dose adjustments
  • When renal function deteriorates (GFR < 30 ml/min/1.73 m²) 1
  • During pregnancy (with careful risk-benefit analysis)

Common Reasons for Discontinuation

The most common reasons patients discontinue lithium include 2:

  • Adverse effects (62% of discontinuations)
  • Psychiatric reasons (44%)
  • Physical health reasons (12%)

The five most common adverse effects leading to discontinuation are:

  • Diarrhea (13%)
  • Tremor (11%)
  • Polyuria/polydipsia/diabetes insipidus (9%)
  • Creatinine increase (9%)
  • Weight gain (7%)

Tapering Schedule

  1. Slow tapering is essential - abrupt discontinuation significantly increases relapse risk 3, 4
  2. Recommended schedule:
    • Reduce by 300mg (or 25-30% of dose) every 2-4 weeks
    • Monitor for emergence of symptoms at each step
    • Total discontinuation period should span at least 1-3 months

Monitoring During Discontinuation

  • Weekly clinical assessments for the first month
  • Biweekly assessments for the second month
  • Monthly assessments for 6-12 months after complete discontinuation
  • Monitor for early signs of relapse (sleep disturbances, mood changes)
  • Serum lithium levels during tapering to confirm adherence to tapering schedule

Special Considerations

Risk of Relapse

Patients should be informed that:

  • Median time to relapse after lithium discontinuation is approximately 1.33 years compared to 7.33 years for those who continue lithium 4
  • The risk of manic recurrence is particularly high in the first weeks after discontinuation 3
  • Some patients may experience lithium-discontinuation-induced refractoriness, where lithium is no longer effective if restarted after discontinuation 5

High-Risk Patients

Extra caution and slower tapering is needed for:

  • Patients with history of severe manic episodes
  • Patients with history of suicide attempts
  • Patients with rapid cycling
  • Patients with type 1 bipolar disorder (more likely to discontinue lithium and refuse medication) 2

Temporary Discontinuation

For temporary discontinuation (e.g., during surgery, contrast imaging):

  • Resume lithium as soon as medically appropriate
  • Consider using alternative mood stabilizers during the interruption period
  • Monitor more frequently during this period

Alternative Treatments

If lithium must be discontinued permanently:

  • Consider valproate as an alternative mood stabilizer 1
  • Atypical antipsychotics may be considered based on individual patient factors 1
  • Combination therapy may be necessary in some cases

Patient Education

Patients and families should be educated about:

  • Early warning signs of relapse
  • The importance of regular follow-up
  • The need to contact healthcare providers immediately if symptoms emerge
  • The risks of self-discontinuation without medical supervision 6

Remember that lithium discontinuation carries significant risks, particularly for patients with bipolar disorder, and should be approached with caution and close monitoring.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.